Oral Minoxidil for Hair Loss: As Good as the Foam, With Different Problems

Minoxidil has been sold as a scalp foam for forty years and as a blood pressure tablet for longer than that. What changed recently is that dermatologists started prescribing the tablet, at a small fraction of the blood pressure dose, to men who were tired of applying liquid to their heads twice a day. It works about as well. It also does something the foam mostly does not, which is grow hair in places you did not ask for.

A blood pressure drug, used sideways

Oral minoxidil was developed as an antihypertensive. The hair growth was an inconvenient side effect, common enough that somebody eventually reformulated it as a topical solution and sold it for the side effect instead. That is the foam in the bathroom cabinet.

Low-dose oral minoxidil reverses that history. Men are typically given 2.5 to 5 mg a day, against blood pressure doses that ran many times higher. It is prescribed off-label. No regulator anywhere has approved a minoxidil tablet for hair loss, which does not make it improper, but does mean the usual approval machinery of dose-finding and long-term safety review has not been applied to this use.

The appeal is obvious to anyone who has tried the topical version. There is no liquid, no drying time, nothing that transfers onto a pillow, and no scalp irritation. Adherence is the whole game in hair loss, and a tablet is easier to keep taking than a twice-daily application for the rest of your life.

The head-to-head trial

Most of what is written about oral minoxidil rests on case series, where everyone knows what they are taking and nobody is compared to anything. There is one randomised trial in men that puts the two forms directly against each other, published in JAMA Dermatology in 2024.

Ninety men were randomised. Sixty-eight completed, the losses largely down to the pandemic, which is a real weakness and worth holding in mind. One group took oral minoxidil 5 mg daily plus a placebo solution; the other applied 5% topical minoxidil twice daily plus a placebo tablet. Everyone was followed for 24 weeks and the primary measure was terminal hair density.

The honest reading is equivalence with a small edge on the crown, from a single modest trial with substantial drop-out. That is a useful result and it is not a landmark. Anyone telling you the tablet is dramatically more effective is going beyond what has actually been shown.

Cost is the other half of the practical picture, and it runs the tablet’s way. The oral course in that trial worked out around $20 for two months. Topical minoxidil typically runs $20 to $30 every month.

Hair in the wrong places

This is the side effect that decides the question for most men, and it is usually mentioned last.

Minoxidil taken by mouth does not know which follicles you care about. Across the wider literature, hypertrichosis affects around 15% of patients overall, with individual studies reporting anywhere from 4% to 93% depending on dose, sex and how carefully anyone looked. In the head-to-head trial it was 49%. The risk rises with dose in a measurable way: roughly a 17.6% increase in risk per additional milligram.

The usual locations are the temples and sideburns, the forearms, the upper lip and the chin. For some men that is a shrug. For others it is the reason to stop, though notably very few actually do: discontinuation because of unwanted hair runs at 0.5% to 1.6%. Most people who get it decide they would rather have it than not have hair on their head, which is a reasonable trade and one you should get to make knowingly rather than discover in a mirror.

The cardiovascular questions, in proportion

Because the parent drug lowers blood pressure, the cardiovascular questions are fair ones. The answers at these doses are reassuring without being empty.

That last row deserves its own sentence, because it is the one that circulates on forums stripped of context. Fluid around the heart is the serious theoretical risk with minoxidil, and at low doses it has produced three published case reports, with the most severe traced to compounding errors that delivered an excessive dose. That is an argument for getting the tablet from a pharmacy with a proper licence rather than an argument against the drug, and it is the same argument that applies to every unregulated men’s health product.

Overall discontinuation for any side effect sits at roughly 0.3% to 4%. The narrative review notes that no routine blood tests or scans are required before or during treatment in an otherwise healthy person, which is a stronger statement of safety than most off-label uses can make.

Who should not take it

The contraindication list is short and specific, and it is the part worth reading twice:

• Phaeochromocytoma
• Recent heart attack
• Heart failure with left ventricular dysfunction
• Severe valve disease
• Advanced chronic kidney disease
• Allergy to minoxidil

A second group should be cautious rather than excluded: men with a history of hypertension, arrhythmia, postural hypotension, peripheral oedema or pericardial disease. The advice there is to start at the minimum dose and increase slowly. If you do not know what your blood pressure is, that is worth establishing before you start a drug that was designed to lower it.

Where it sits next to finasteride

Minoxidil in any form does not touch the cause of male pattern hair loss. It does not block DHT, it does not slow the miniaturisation of follicles, and it stops working when you stop taking it. What it does is push follicles into and through the growth phase. Finasteride works on the cause and has the larger effect. The trials on both are worth reading in the original numbers, and the side-effect literature on finasteride is genuinely contested in a way minoxidil’s is not.

So the sensible way to think about the tablet is not as an upgrade. It is the same molecule you already knew about, delivered in a way that is easier to keep taking, at the cost of some hair you did not want. If the foam is working and you do not mind applying it, there is no particular reason to switch. If you stopped using it because you could not face doing it twice a day forever, this is the version that solves that problem, and the early shedding phase applies just the same.

This article is for information only and is not medical advice. It cannot account for your individual circumstances. Talk to a doctor about your own situation, particularly before starting or stopping any prescription medication.